Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

We’re excited to announce an update to NeuroQuant MS: a simplified and more intuitive method for analyzing lesion dynamics across multiple timepoints. With the release of version 5.0, this enhancement provides clearer insights into lesion changes, aiding in the understanding of disease progression.

The Updated NeuroQuant MS Lesion Dynamics

The NeuroQuant FLAIR module, a cornerstone of our MS solution, processes 3D T1 and T2 FLAIR images to provide information on brain lesions characterized by hyperintensities in the T2 FLAIR images using a static deep-learning model.

If earlier scans for the patient have been processed on the system, the output will now include a new series that visualizes color-coded changes in lesions over time. The updated algorithm, released in version 5.0, simplifies the way lesion dynamics are computed across two timepoints. By using segmentation masks from both the current and prior studies, the system now calculates and visualizes lesion changes, offering more intuitive data with clearer labeling and improved visualization of affected areas.

Breaking Down the Lesion Dynamics Report

The DICOM output visualizes areas of change and aligns with the updated Lesion Dynamics Table in the NeuroQuant MS report, providing key insights into lesion burden:

  • Prior lesion burden = Stable + Shrinking (Represents the sum of Stable and Shrinking lesions)
  • Current lesion burden = Stable + New + Enlarging (Represents the sum of Stable, New, and Enlarging lesions.)

A New Way to Visualize Change

The colors used in the visual output enhance the clarity of lesion change data:

  • Red: New lesions
  • Orange: Enlarging lesions
  • Green: Stable lesions
  • Blue: Shrinking lesions

Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression   Cortechs.ai | Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Customization for Your Needs

We’ve also introduced configurable parameters for enhanced flexibility. You can now configure the minimum voxel count for thresholding absolute change and adjust percent volume change. This color-coding allows for quick identification and analysis of lesion changes over time.

This update to NeuroQuant MS provides a more straightforward and informative way to track and understand lesion dynamics, enhancing the value of NeuroQuant in clinical practice.

For more detailed information on thresholds, current customers can refer to the NeuroQuant User Manual.

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care
Scroll to Top